FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Korro Bio's Free Cash Flow for the
three
months ended in Dec. 2024 was $-8.95 Mil. Korro Bio's Revenue for the
three
months ended in Dec. 2024 was $2.27 Mil. Therefore, Korro Bio's FCF Margin % for the quarter that ended in Dec. 2024 was -393.97%.
The historical rank and industry rank for Korro Bio's FCF Margin % or its related term are showing as below:
KRRO'
s FCF Margin % Range Over the Past 10 Years
Min: -3433.55 Med: -3433.55 Max: -3433.55
Current: -3433.55
During the past 4 years, the highest FCF Margin % of Korro Bio was -3433.55%. The lowest was -3433.55%. And the median was -3433.55%.
KRRO's FCF Margin % is ranked worse than 86.32% of 1009
companies
in the Biotechnology industry
Industry Median: -128.43
vs KRRO: -3433.55
Korro Bio FCF Margin % Historical Data
The historical data trend for Korro Bio's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Korro Bio's FCF Margin %
For the Biotechnology subindustry, Korro Bio's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Korro Bio's FCF Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Korro Bio's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Korro Bio's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Korro Bio FCF Margin % Related Terms
Thank you for viewing the detailed overview of Korro Bio's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
KRRO has been successfully added to your 